Showing 9,521 - 9,528 results of 9,528 for search '(( 10 nm decrease ) OR ( 50 ((((ng decrease) OR (we decrease))) OR (nn decrease)) ))', query time: 0.32s Refine Results
  1. 9521

    Table1_The efficacy and safety of dachaihu decoction in the treatment of type 2 diabetes mellitus: A systematic review and meta-analysis.DOCX by Zehua Zhang (312656)

    Published 2022
    “…<p>Background: Type 2 diabetes mellitus (T2DM) is a clinical metabolic syndrome characterized by persistent hyperglycemia, which is caused by defective insulin secretion and decreased function in regulating glucose metabolism. …”
  2. 9522

    Table2_The efficacy and safety of dachaihu decoction in the treatment of type 2 diabetes mellitus: A systematic review and meta-analysis.DOCX by Zehua Zhang (312656)

    Published 2022
    “…<p>Background: Type 2 diabetes mellitus (T2DM) is a clinical metabolic syndrome characterized by persistent hyperglycemia, which is caused by defective insulin secretion and decreased function in regulating glucose metabolism. …”
  3. 9523

    Robotic-Assisted Median Arcuate Ligament Release With Celiac Artery Lysis and Celiac Ganglion Neurolysis by G. Kimble Jett (6509428)

    Published 2020
    “…Minimally invasive techniques using laparoscopy have resulted in decreased morbidity, quicker recovery, and reduced pain (5-8). …”
  4. 9524

    Table_1_Effects of sacubitril/valsartan in ESRD patients undergoing hemodialysis with HFpEF.docx by Yanhong Guo (270212)

    Published 2022
    “…Among those 247 patients with MHD, 211 patients were already in treatment with angiotensin converting enzyme inhibitors (ACEi)/angiotensin receptor blockers (ARBs) before being treated with sacubitril/valsartan. We also performed an analysis to compare the differences between the 211 patients who had previously received ACEi/ARB treatment and the 36 patients who were sacubitril/valsartan naive.…”
  5. 9525

    A single systemic prophylactic treatment with CpG-C results in long-term reduction of metastatic burden in the brain. by Amit Benbenishty (6524375)

    Published 2019
    “…<p>(<b>a</b>) In the experimental metastasis models, we used the aECAi approach [<a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.2006859#pbio.2006859.ref032" target="_blank">32</a>] for injection of tumor cells (see <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.2006859#sec002" target="_blank">Methods</a>): a method that improves brain targeting and preserves cerebral hemodynamics. …”
  6. 9526

    PDLB - Balance Sheet by Nguyen Linh (19516642)

    Published 2024
    “…</p><p><br></p><p dir="ltr">ECIP capital: PDLB received $225M of ECIP capital, and the regulators assigned them the lowest possible dividend (0.5%) on this capital for the first year of payments (announced in June). If we assume PDLB continues to pay 0.5% on this preferred and they have a cost of preferred equity of 10%, then we can calculate the value of this $225M liability as just $11M, with the rest a write-up to equity.…”
  7. 9527

    Update on trimethylamine N-oxide (TMAO) as a piezolyte and cryoprotectant: its role in a depth limit for marine fishes and loss from hadal fish during capture by Paul Yancey (14354982)

    Published 2025
    “…</p><p dir="ltr">Jamieson AJ, Yancey PH (2012). doi/10.1086/BBLv222n3p171</p><p dir="ltr">Lantz C, Xi Z, Rider RL, Walker TE, Hebert M, Russell DH (2024). doi.org/10.1021/acs.jpcb.4c04951</p><p dir="ltr">Laurent H, Youngs TGA, Headen TF, Soper AK, Dougan L (2022). doi.org/10.1038/s42004-022-00726-z</p><p dir="ltr">Li X, Wang C, Yanagita T, Xue C, Zhang T, Wang Y (2024). doi.org/10.1021/acs.jafc.4c01974</p><p dir="ltr">Linley T, Gerringer M, Yancey PH, Drazen JC, Weinstock C, Jamieson A (2016). doi.org/10.1016/j.dsr.2016.05.003</p><p dir="ltr">Liu Q, Jiang S, Li W, Pan B, Xu Q (2022). doi.org/10.3390/jmse10040454</p><p dir="ltr">Liu T-H, Okuno M (2024). doi.org/10.1039/D4CP01025F</p><p dir="ltr">Loo RL, Chan Q, Nicholson JK, Holmes E (2022). doi.org/10.1021/acs.jproteome.1c00851</p><p dir="ltr">Mueller-Dieckmann C, Kauffmann B, Weiss MS (2011). doi.org/10.1107/S0021889811000</p><p dir="ltr">Mu Y, Bian C, Liu R, Wang Y, Shao G, Li J, et al. (2021). doi.org/10.1371/journal.pgen.1009530</p><p dir="ltr">Raymond JA, Devries AL (1998). doi.org/10.1023/a:1007778728627</p><p dir="ltr">Raymond JA, Hassel A (2005). doi.org/10.1111/j.1095-8649.2000.tb02240.x</p><p dir="ltr">Roche J, Royer CA (2018). doi.org/10.1098/rsif.2018.0244</p><p dir="ltr">Samerotte AL, Drazen JC, Brand GL, Seibel BA, Yancey PH (2007). doi/10.1086/510566</p><p dir="ltr">Swan JA, Jamieson AJ, Linley TD, Yancey PH (2021). doi.org/10.1093/jcbiol/ruaa102</p><p dir="ltr">Treberg JR, Bystriansky JS, Driedzic WR (2005). doi.org/10.1002/jez.a.140</p><p dir="ltr">Wang K, Shen Y, Yang Y, Gan X, Liu G, Hu K, et al. (2019). doi.org/10.1038/s41559-019-0864-8</p><p dir="ltr">Xu H, Fang C, Xu W, Wang C, Song Y, Zhu C, et al. (2025). doi.org/10.1016/j.cell.2025.01.002</p><p dir="ltr">Yancey PH, Speers-Roesch B, Atchison A, Reist JD., Treberg JR (2018). doi.org/10.1086/696157</p><p dir="ltr">Yancey PH (2020). doi.org/10.1002/jez.2354</p><p dir="ltr">Yancey PH (2023). doi/10.33594/000000661</p>…”
  8. 9528

    Figure S1-S21 from miR-196b-5p Regulates Colorectal Cancer Cell Migration and Metastases through Interaction with HOXB7 and GALNT5 by Verena Stiegelbauer (4582930)

    Published 2024
    “…(A-B) In cohort 1, miR-196b-5p expression decreased with (A) higher tumor stage, whereas no difference could be observed for (B) tumor grade. …”